1. A method for treating and/or preventing a disorder associated with disrupted autophagosome maturation in a subject, wherein the disorder is cancer, gastritis, peptic ulcer disease, or an infection resulting from Helicobacter pylori, Salmonella typhimurium, Listeria, Shigella, Legionella pneumophila, Staphylococcus aureus, Mycobacterium tuberculosis, Group A Streptococcus, Epstein-Barr virus (EBV), Hepatitis B or C, human immunodeficiency virus, herpes simplex virus, influenza virus, human respiratory syncytial virus, or cytomegalovirus; the method comprising administering an agent that promotes autophagosome maturation to the subject.
|